Showing results (111-120 of 159) with videos related to

Sort By:
Pageof 16
British Journal of Clinical Pharmacology|September 5, 2002
Non-antiarrhythmic drugs prolonging the QT interval: considerable use in seven countriesFabrizio De Ponti, Elisabetta Poluzzi, Alberto Vaccheri, et al.
Thrombosis and Haemostasis|January 17, 2003
Acute thrombocytopenia in patients treated with the oral glycoprotein IIb/IIIa inhibitors xemilofiban and orbofiban: evidence for an immune etiologyJacqueline A Brassard, Brian R Curtis, Richard A Cooper, et al.
Cell|April 17, 2002
P-Rex1, a PtdIns(3,4,5)P3- and Gbetagamma-regulated guanine-nucleotide exchange factor for RacHeidi C E Welch, W John Coadwell, Christian D Ellson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 20, 2006
RhoG regulates the neutrophil NADPH oxidaseAlison M Condliffe, Louise M C Webb, G John Ferguson, et al.
Internal Medicine Journal|April 11, 2026
Annual magnetic resonance cholangiopancreatography surveillance outcomes in individuals with primary sclerosing cholangitisGary Dezhi Zhang, Chloe Attree, Nazneen Irani, et al.
Journal of Gastroenterology and Hepatology|February 10, 2020
The MAAPE score in intermediate and advanced hepatocellular carcinoma treated with Yttrium-90 resin microsphere radioembolizationMichael C Wallace, Shaun Samuelson, Tiffany Khoo, et al.
Respiratory Research|August 24, 2017
IL-18 associated with lung lymphoid aggregates drives IFNγ production in severe COPDEmmanuel Briend, G John Ferguson, Michiko Mori, et al.
Nature Cell Biology|October 17, 2006
Gbetagammas and the Ras binding domain of p110gamma are both important regulators of PI(3)Kgamma signalling in neutrophilsSabine Suire, Alison M Condliffe, G John Ferguson, et al.
Digestive Diseases and Sciences|August 24, 2019
Baseline and Post-treatment 18F-Fluorocholine PET/CT Predicts Outcomes in Hepatocellular Carcinoma Following Locoregional TherapyMichael C Wallace, Kenny Sek, Roslyn J Francis, et al.
Pageof 16